Sanofi CEO Addresses Long-Term Outlook Via Regeneron Alliance, Jefferies Says
Sanofi's expanded alliance with Regeneron Pharmaceuticals marks the French drugmaker's first step toward addressing its long-term outlook and indicates progress under new CEO Belen Garijo, according to Jefferies analysts. The analysts note that while the assets are early-stage, they represent a clear sign of progress.